Direct supplementation with Urolithin A overcomes limitatio…

Atlantia is a world-class provider of human clinical studies. For over a decade we have delivered clinical results to our many clients around the world, on time and on budget. We strive to offer the highest quality science while maintaining a cost-conscious approach to maximize the value proposition for each of our clients.


Direct supplementation with Urolithin A overcomes limitations of’dietary exposure and gut microbiome variability in healthy adults’to achieve consistent levels across the population
1

Abstract
1

Introduction
1

Methods
2

Study design and participant demographics
2

Inclusion and exclusion criteria
2

Investigational products and randomization
2

Blood and fecal samples collection
3

UA bioavailability measurements
4

Quantification of ellagic acid, punicalagins, and UA in commercial grade food products and dietary supplements
4

Shotgun metagenomic sequencing and analysis of microbiome
5

Safety assessments
5

Statistical analysis
5

Results
6

Determination of dietary precursor levels in pomegranate-based supplements and juice
6

Compliance to study products and safety
6

The majority of the study population failed to produce UA following dietary exposure to PJ
6

Gut microbiome plays an essential role in defining UA producers
7

UA producer and non-producer exhibit differentially abundant gut microbiome taxa
8

Direct oral supplementation with Urolithin A delivers significantly higher levels than PJ
8

Discussion
9

Compliance with ethical standards
11

ACKNOWLEDGMENTS
11

References
11

atlantiaclinicaltrials.com

Powered by